New gut bacteria treatment tested for rare liver disease
Disease control
Recruiting now
This study is testing an investigational capsule called LB P8 in adults with primary sclerosing cholangitis (PSC), a rare liver disease. Researchers want to see if the treatment is safe and if it can lower a key liver enzyme (ALP) that indicates disease activity. Participants wil…
Phase: PHASE2 • Sponsor: LISCure Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC